Exametazime
Exametazime (HMPAO) (for the preparation of Tc99m Exametazime injection)
Approved
Approval ID
6ea1fd48-c649-4e05-856e-bb123ce40a3f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 1, 2012
Manufacturers
FDA
AnazaoHealth Corporation
DUNS: 011038762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Exametazime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51808-214
Product Classification
G
Generic Name
Exametazime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 28, 2012
FDA Product Classification
INGREDIENTS (3)
EXAMETAZIMEActive
Quantity: 1 mg in 1 1
Code: G29272NCKL
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 6.75 mg in 1 1
Code: 451W47IQ8X
Classification: IACT
STANNOUS CHLORIDEInactive
Quantity: 11.4 ug in 1 1
Code: 1BQV3749L5
Classification: IACT